バイオフロンテラ
Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.05 | $12M | -$2M |
| 2026 Q1 | -0.41 | $10M | -$75,000 |
| 2025 Q4 | 0.48 | $17M | -$2M |
| 2025 Q3 | -0.62 | $7M | -$4M |
| 2025 Q2 | -0.57 | $9M | -$3M |
| 2025 Q1 | -0.76 | $9M | -$4M |
| 2024 Q4 |
| -0.19 |
| $13M |
| -$1M |
| 2024 Q3 | -0.98 | $9M | -$1M |